Retinal dysplasia in mice lacking p56(lck)

Oncogene

Volumn 16, Issue 18, 1998, Pages 2351-2356

  Omri, B ^a,c   Blancher, C ^a   Neron, B ^a   Marty, M C ^a   Rutin, J ^a   Molina, T J ^b   Pessac, B ^a   Crisanti, P ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Dysplasia; Lck; Neuroretina

Indexed keywords

COMPLEMENTARY DNA; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE DISRUPTION; GENE EXPRESSION; GENE ISOLATION; MOUSE; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTO ONCOGENE; RETINA DETACHMENT; RETINA MALFORMATION; RETINA NERVE CELL; RETROLENTAL FIBROPLASIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROSETTE FORMATION;

EID: 0032493076     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201761     Document Type: Article

References (28)

1. Chomczynski PQ and Asba PK. (1984). Biochem. Biophs. Res. Comm., 122, 340.
2. Fischer S, Fagard R, Boulet I and Gesquiere JC. (1987). Biochem. Biophys. Res. Comm., 143, 819-826.
3. Flexner RA. (1981). Johns Hopkins Hops. Bull, 2, 115-119.
4. Grant SGN, O'Dell TJ, Karl KA, Stein PL. Soriano P and Kandel ER. (1992). Science, 258, 1903-1910.
5. Groves T, Smiley MP, Forbush K, Perlmutter RM and Guidos CJ. (1996). Immunity, 5, 417-428.
6. Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C and Jackson KL. (1986). Am. J. Ophtalmol., 102, 1-6.
7. Ignelzi Jr MA, Miller DR, Soriano P and Maness PF. (1994). Neuron, 12, 873-884.
8. Ingraham CA, Cooke MP, Chuang YN, Perlmutter RM and Maness PF. (1992). Oncogene, 7, 95-100.
9. Maness PF, Aubry M, Shores CG, Frame L and Pfenninger KH. (1988). Proc. Natl. Acad. Sci. USA, 85, 5001-5005
10. Marth JD, Cooper JA, King CS, Ziegler SF, Tinker DA, Overall RW, Krebs EG and Perlmutter RM. (1988). Mol. Cell. Biol., 8, 540-550.
11. Marth JD, Peet R, Krebs EG and Perlmutter RM. (1985). Cell, 43, 393-404.
12. Molina TJ, Kishihura K, Siderovski DP, Van Ewijk W, Narendran A, Timms E, Wakeham A, Paige CJ, Hartmann KU, Veillette A, Davidson D and Mak TW. (1992). Nature, 357, 161-164.
13. Omri B, Crisanti P, Alliot F, Marty MC, Rutin J, Levalleis C, Privat A and Pessac B. (1994). Int. Immunol. 6, 377-385.
14. Omri B, Crisanti P, Marty MC, Alliot F, Fagard R, Molina T and Pessac B. (1996). J. Neurochemistry, 67, 1360-1364.
15. Penn JS, Tolman BL, Lowery LA and Koutz CA. (1992). Curr. Eye Res., 11, 939-953.
16. Popoff N and Ellsworth RM. (1969). J. Ultrastruct. Res., 29, 535-549.
17. Quinn GE., Johnson L, Otis C, Schaffen DB and Bowen FW. (1990). Doc. Ophtalmol., 74, 223-228.
18. Rajaofetra N, Poulal P, Marlier L, Geffard M and Privat A. (1992). Dev. Brain. Res., 67, 237.
19. Sadda SR, Yu YS, De Juan Jr E, Rencs EV, Green WR and Gottsch JD. (1994). Invest. Ophtalmol., 35, 1202-1211.
20. Silverstein AM, Osburn BI and Prendergast RA. (1971). Am. J. Ophtalmol., 72, 13-21.
21. Sira BS, Nissenkorn I and Kremer I. (1985). Surv. Ophtalmol., 33, 1-16.
22. Sorge LK, Levy BT and Maness PF. (1984). Cell, 36, 249-257.
23. Ts'o MOM. (1969). Arch. Path. 88, 664-671.
24. Van Oers NSC, Lowin-Kropf B, Finlay D, Conolly K and Weiss A. (1996). Immunity, 5, 429-439.
25. Van Tan H, Allee G, Benes C, Viammey Barnier J, Vincent JD and Fagard R. (1996). J. Neurochem., 67, 2306-2315.
26. Yagi T. (1994). Develop. Growth and Differ., 36, 543-550.
27. Yarden Y and Ullrich A. (1988). Ann. Rev. Biochem., 57, 443-478.
28. Zierler S. (1988). Retinopathy of prematurity: Problem and Challenge. Flynn JT. and Phelps DL. (Eds) Alan R. Liss, New York. pp. 23-33.